Based in New York, New York, Thompson Dean leads Avista Capital Partners as co-founder and chief executive officer. In this role, Thompson Dean pursues transformative acquisition strategies that include growth-focused buyouts. In November 2017, Avista reached an agreement with Express Scripts Holding Company for the acquisition of its wholly-owned subsidiary United BioSource (UBC).
In business for 15 years, UBC has maintained a leading presence in patient support and pharmaceutical services, with an emphasis on making medical products and drugs more accessible and safe. With 13 locations across North America and Europe, the Pennsylvania-based firm excels in generating and evaluating real-world evidence that informs the life cycles of medical products.
Executives with both companies described the acquisition as an ideal partnership that will help the firms thrive in a dynamic and expanding industry, all while improving patient care. The companies’ combined health care sector expertise sets them on a path to enable more biopharmaceutical companies to accelerate therapy approvals, in the process expanding access to essential medications and therapies.
